Differences in clinical characteristics, management and short-term outcome between acute heart failure patients chronic obstructive pulmonary disease and those without this co-morbidity

Clinical Research in Cardiology

Volumn 103, Issue 9, 2014, Pages 733-741

  Parissis, John T ^a,f   Andreoli, Chiara ^b   Kadoglou, Nikolaos ^a   Ikonomidis, Ignatios ^a   Farmakis, Dimitrios ^a   Dimopoulou, Ioanna ^a   Iliodromitis, Efstathios ^a   Anastasiou Nana, Maria ^a   Lainscak, Mitja ^c   Ambrosio, Giussepe ^b   Mebazaa, Alexandre ^d   Filippatos, Gerasimos ^a   Follath, Ferenc ^e  

^a NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^d HÔPITAL LARIBOISIÈRE   (France)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f Department of Internal Medicine University Hospital Zurich ^*  (Greece)

Author keywords

Acute heart failure; Chronic obstructive pulmonary disease; Medications; Mortality

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT; LEVOSIMENDAN; NITRIC ACID DERIVATIVE;

ACUTE HEART FAILURE; AUSTRALIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE REGISTRY; EUROPE; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEXICO; MORTALITY; OBESITY; OBSERVATIONAL STUDY; PERIPHERAL VASCULAR DISEASE; POSITIVE END EXPIRATORY PRESSURE; RETROSPECTIVE STUDY; REVIEW; TURKEY (REPUBLIC); ACUTE DISEASE; AGE; AGED; CLINICAL TRIAL; COMPLICATION; EVIDENCE BASED MEDICINE; HEART FAILURE; MIDDLE AGED; MULTICENTER STUDY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTER; RISK FACTOR;

ACUTE DISEASE; AGE FACTORS; AGED; EVIDENCE-BASED MEDICINE; FEMALE; HEART FAILURE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84905963346     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-014-0708-0     Document Type: Review

References (46)

1. Funk GC, Bauer P, Burghuber OC, Fazekas A, Hartl S, Hochrieser H, Schmutz R, Metnitz P (2012) Prevalence and prognosis of chronic obstructive pulmonary disease in critically Ill patients between 1998 and 2008. Eur Respir J [Epub ahead of print]
2. Dickstein K, Cohen-Solal A, Filippatos G, McMurray JJ, Ponikowski P, Poole-Wilson PA, Stromberg A, van Veldhuisen DJ, Atar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, Priori SG, Swedberg K (2008) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 29:2388-2442
3. Hawkins NM, Petrie MC, Jhund PS, Chalmers GW, Dunn FG, McMurray JJ (2009) Heart failure and chronic obstructive pulmonary disease: diagnostic pitfalls and epidemiology. Eur J Heart Fail 11:130-139
4. Padeletti M, Jelic S, LeJemtel TH (2008) Coexistent chronic obstructive pulmonary disease and heart failure in the elderly. Int J Cardiol 125:209-215
5. Kociol RD, Greiner MA, Hammill BG, Eapen ZJ, Fonarow GC, Klaskala W, Mills RM, Curtis LH, Hernandez AF (2012) B-type natriuretic peptide level and postdischarge thrombotic events in older patients hospitalized with heart failure: insights from the Acute Decompensated Heart Failure National Registry. Am Heart J 163:994-1001
6. Adams KF Jr, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo, Abraham WT, Berkowitz RL, Galvao M, Horton DP, ADHERE Scientific Advisory Committee and Investigators (2005) Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J 149:209-216 (Pubitemid 40348525)
7. Fonarow GC, Abraham WT, Albert NM, Gattis WA, Gheorghiade M, Greenberg B, O'Connor CM, Yancy CW, Young J (2004) Organized program to initiate life saving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design. Am Heart J 148:43-51 (Pubitemid 38900479)
8. Mentz RJ, Fiuzat M, Wojdyla DM, Chiswell K, Gheorghiade M, Fonarow GC, O'Connor CM (2012) Clinical characteristics and outcomes of hospitalized heart failure patients with systolic dysfunction and chronic obstructive pulmonary disease: findings from OPTIMIZE-HF. Eur J Heart Fail 14:395-403
9. Komajda M, Follath F, Swedberg K, Cleland J, Aguilar JC, Cohen-Solal A, Dietz R, Gavazzi A, Van Gilst WH, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003) The EuroHeart Failure survey programme-a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. Eur Heart J 24:464-474 (Pubitemid 36286188)
10. Nieminen, Brutsaert D, Dickstein K, Drexler H, Follath F, Harjola VP, Hochadel M, Komajda M, Lassus J, Lopez-Sendon JL, Ponikowski P, Tavazzi L, on behalf of the EuroHeart Survey Investigators (2006) EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population. Eur Heart J 27:2725-2736
11. Zannad F, Mebazaa A, Juillière Y, Cohen-Solal A, Guize L, Alla F, Rougé P, Blin P, Barlet MH, Paolozzi L, Vincent C, Desnos M, Samii K, for the EFICA Investigators (2006) Clinical profile, contemporary management and one-year mortality in patients with severe acute heart failure syndromes: the EFICA study. Eur J Heart Fail 8:697-705 (Pubitemid 44754746)
12. Tavazzi L, Maggioni AP, Lucci D, Cacciatore G, Ansalone G, Oliva F, Porcu M (2006) Nationwide survey on acute heart failure in cardiology ward services in Italy. Eur Heart J 27:1207-1215
13. Follath F, Yilmaz MB, Delgado JF, Parissis JT, Porcher R, Gayat E, Burrows N, McLean A, Vilas-Boas F, Mebazaa A (2011) Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARMHF). Intensive Care Med 37:619-626
14. Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dichstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thegesen K (2005) Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of Cardiology. Eur Heart J 26:384-416 (Pubitemid 40283098)
15. Parissis JT, Ikonomidis I, Rafouli-Stergiou P, Mebazaa A, Delgado J, Farmakis D, Vilas-Boas F, Paraskevaidis I, Anastasiou-Nana M, Follath F (2011) Clinical characteristics and predictors of in-hospital mortality in acute heart failure with preserved left ventricular ejection fraction. Am J Cardiol 107:79-84
16. Mebazaa A, Parissis J, Porcher R, Gayat E, Nikolaou M, Boas FV, Delgado JF, Follath F (2011) Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods. Int Care Med 37:290-301
17. Böhm M, Link A, Cai D, Nieminen MS, Filippatos GS, Salem R, Cohen Solal A, Huang B, Padley RJ, Kivikko M, Mebazaa A (2011) Beneficial association of β-blocker therapy on recovery from severe acute heart failure treatment: data from the survival of patients with acute heart failure in need of intravenous inotropic support trial. Crit Care Med 39:940-944
18. Page RL 2nd, Lindenfeld J (2012) The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient. Curr Cardiol Rep 14:276-284
19. Hawkins NM, Jhund PS, Simpson CR, Petrie MC, Macdonald MR, Dunn FG, Macintyre K, McMurray JJ (2010) Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland. Eur J Heart Fail 12:17-24
20. Barnes PJ (2010) Chronic obstructive pulmonary disease: effects beyond the lungs. PLoS Med 7:e1000220
21. Suskovic S, Kosnik M, Lainscak M (2010) Heart failure and chronic obstructive pulmonary disease: two for tea or tea for two? World J Cardiol 2:305-307
22. Divo M, Cote C, de Torres JP, Casanova C, Marin JM, Pinto-Plata V, Zulueta J, Cabrera C, Zagaceta J, Hunninghake G, Celli B, BODE Collaborative Group (2012) Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:155-161
23. Kollert F, Muller C, Tippelt A, Jorres RA, Heidinger D, Probst C, Pfeifer M, Budweiser S (2011) Anaemia in chronic respiratory failure. Int J Clin Pract 65:479-486
24. Huertas A, Palange P (2011) COPD: a multifactorial systemic disease. Ther Adv Respir Dis 5:217-224
25. Corsonello A, Antonelli Incalzi R, Pistelli R, Pedone C, Bustacchini S, Lattanzio F (2011) Comorbidities of chronic obstructive pulmonary disease. Curr Opin Pulm Med 17 Suppl 1:S21-S28
26. Singh S, Loke YK, Enright P, Furberg CD (2012) Pro-arrhythmic and pro-ischaemic effects of inhaled anticholinergic medications. Thorax 68:114-116
27. Bhatt SP, Nanda S, Kintzer JS (2012) Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease. Respir Med 106:1134-1138
28. Fuschillo S, Martucci M, Donner CF, Balzano G (2012) Airway bacterial colonization: the missing link between COPD and cardiovascular events? Respir Med 106:915-923
29. Medina AM, Marteles MS, Sáiz EB, Martínez SS, Laiglesia FR, Rodríguez JA, Pérez-Calvo JI (2011) Prognostic utility of NTproBNP in acute exacerbations of chronic pulmonary diseases. Eur J Intern Med 22:167-171
30. Taylor DM, Fui MN, Chung AR, Gani L, Zajac JD, Burrell LM (2012) A comparison of precipitants and mortality when acute decompensated heart failure occurs in the community and hospital settings. Heart Lung Circ 21:439-443
31. Rudiger A, Streit M, Businger F, Schmid ER, Follath F, Maggiorini M (2010) The impact of infections on critically ill acute heart failure patients: an observational study. Swiss Med Wkly 18(140):w13125
32. O'Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M (2005) Demographics, clinical characteristics, and outcomes of patients hospitalized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail 11:200-205 (Pubitemid 40462423)
33. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, ESC Committee for Practice Guidelines (2012) ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the task force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the heart failure association (HFA) of the ESC. Eur Heart J 33:1787-1847
34. Mainguy V, Girard D, Maltais F, Saey D, Milot J, Sénéchal M, Poirier P, Provencher S (2012) Effect of bisoprolol on respiratory function and exercise capacity in chronic obstructive pulmonary disease. Am J Cardiol 110:258-263
35. Ekman I, Andersson G, Boman K, Charlesworth A, Cleland JG, Poole-Wilson P, Swedberg K (2006) Adherence and perception of medication in patients with chronic heart failure during a five-year randomised trial. Patient Educ Couns 61:348-353 (Pubitemid 43841742)
36. Rutten FH, Cramer MJ, Grobbee DE, Sachs AP, Kirkels JH, Lammers JW, Hoes AW (2005) Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary disease. Eur Heart J 261:887-894
37. Guazzi M (2003) Alveolar-capillary membrane dysfunction in heart failure: evidence of a pathophysiologic role. Chest 124:1090-1102
38. Staszewsky L, Wong M, Masson S, Barlera S, Carretta E, Maggioni AP, Anand IS, Cohn JN, Tognoni G, Latini R (2007) Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: data from the Val-HeFT heart failure trial. J Card Fail 13:797-804 (Pubitemid 350214524)
39. Sin DD, Man SF (2005) Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 83:8-13 (Pubitemid 40754770)
40. Rusinaru D, Saaidi I, Godard S, Mahjoub H, Battle C, Tribouilloy C (2008) Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol 101:353-358 (Pubitemid 351162971)
41. Macchia A, Monte S, Romero M, D'Ettorre A, Tognoni G (2007) The prognostic influence of chronic obstructive pulmonary disease in patients hospitalised for chronic heart failure. Eur J Heart Fail 9:942-948 (Pubitemid 47332320)
42. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM (2005) The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 165:55-61 (Pubitemid 40096082)
43. Blum A, Simsolo C, Sirchan R, Haiek S (2011) "Obesity paradox" in chronic obstructive pulmonary disease. Isr Med Assoc J 13:672-675
44. Arnaudis B, Lairez O, Escamilla R, Fouilloux A, Fournier P, Monteil B, Bouisset F, Arnal JF, Elbaz M, Carrié D, Roncalli J, Pathak A, Galinier M (2012) Impact of chronic obstructive pulmonary disease severity on symptoms and prognosis in patients with systolic heart failure. Clin Res Cardiol 101:717-726
45. Steinacher R, Parissis JT, Strohmer B, Eichinger J, Rottlaender D, Hoppe UC, Altenberger J (2012) Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure. Clin Res Cardiol 101:637-645
46. Caglar IM, Dasli T, Turhan Caglar FN, Teber MK, Ugurlucan M, Ozmen G (2012) Evaluation of atrial conduction features with tissue Doppler imaging in patients with chronic obstructive pulmonary disease. Clin Res Cardiol 101:599-606